Reducing Antacid Use in a Level IV NICU: A QI Project to Reduce Morbidity

INTRODUCTION: Gastroesophageal reflux is a physiologic occurrence in infants. Clinicians caring for neonates use histamine-2 receptor antagonists (H2As) or proton pump inhibitors (PPIs) for symptomatic reflux, apnea/bradycardia/desaturations, or irritability. Recent studies have shown that there is...

Descripción completa

Detalles Bibliográficos
Autores principales: Reinhart, Richelle M., McClary, Jacquelyn D., Zhang, Mengqi, Marasch, Jaime L., Hibbs, Anna Maria, Nock, Mary L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Individual QI Projects from Single Institutions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297399/
https://www.ncbi.nlm.nih.gov/pubmed/32607459
http://dx.doi.org/10.1097/pq9.0000000000000303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297399/
https://www.ncbi.nlm.nih.gov/pubmed/32607459
http://dx.doi.org/10.1097/pq9.0000000000000303

Ejemplares similares